When Insurance Coverage Dictates Cancer Therapy
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Blood-Cancer.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Financial Toxicity (Financial Distress) and Cancer Treatment (PDQ®)–Patient Version. National Cancer Institute. Available at https://www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-pdq
- CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers. National Cancer Institute. Available at https://www.cancer.gov/about-cancer/treatment/research/car-t-cells
- Medicare sets outpatient CAR T-cell therapy rates. Hematology News. Available at https://www.mdedge.com/hematologynews/article/164403/business-medicine/medicare-sets-outpatient-car-t-cell-therapy-rates